Nichols Weston's Form 4 filing
Neuphoria Therapeutics Inc. (NEUP) · filed Oct 23, 2025
- Accession no.
- 0000902664-25-004536
- Filed
- Oct 23, 2025, 7:49 PM ET
- Trade date
- Oct 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $3.28M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nichols WestonCIK 0001746376 | 10% Owner |
| Lynx1 Capital Management LPCIK 0001910456 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2025 | Common stock, $0.00001 par value per share | PPurchaseAcquired | +639,110 | $5.14 | +$3,283,108.07 | 875,328 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.